ASOKE WELLNESS SERVICE · 01
Autologous AMPC Cell Therapy
Advantages of Autologous AMPC Cell Therapy
Uses your own cells
Reduces the chance of immune rejection compared with cells from another person, and reduces the risk of disease transmission from a donor.
May help reduce inflammation
The cells can secrete biological substances (growth factors and cytokines) that help reduce inflammation and promote tissue recovery.
Promotes tissue repair
Studies indicate it can support the recovery of cartilage, tendons, muscle and certain tissues — particularly in regenerative medicine and some joint conditions.
Favorable safety record
Many studies report that serious adverse events are rare when cells are correctly prepared and administered in a medical facility that meets proper standards.
Personalized therapy
Because the cells come from the patient's own body, the treatment aligns with the concept of care tailored to each individual.
Clinical Use and Safety
Safety Profile
To date, across data from many thousands of treated recipients, no serious adverse events have been reported — indicating a high level of clinical safety, thanks to the following factors:
- 100% your own cells — fully autologous & biologically compatible
- No genetic modification
- No cell culture — reducing the risk of cell mutation and making the therapy safer for clinical use
- Comprehensive pre-release quality testing before administration
Closed-System Manufacturing Process
- 01
Blood Collection
- 250 mL to 300 mL of blood collected
- 02
Cell Separation
- Cells processed in the ASCT patented microenvironment for 3–6 days
- Targeted leukocyte suspensions range from 1×10⁸ – 1×10⁹
- No viruses, antibiotics, growth factors, or reagents added
- 03
Biotest
- Tests for contamination
- Samples are tested by an accredited external laboratory for endotoxins, mycoplasma and microbial contamination
- 04
AMPC Reinfusion
- Subcutaneous allergy test with 1 ml of sample
- Administration route is determined by the physician
